Back
Corporate News
Cohance Lifesciences files certificates with BSE and NSE, complying with SEBI regulations
07-Oct-2026, 07:35
Cohance Lifesciences Limited, formerly known as Suven Pharmaceuticals Limited, submitted Confirmation Certificates issued by KFin Technologies Limited, its Registrar and Share Transfer Agent, for the quarter ended September 30, 2026, in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018, to the BSE Limited and National Stock Exchange of India Limited.
